Vaxcyte (PCVX) Prepaid Assets (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Prepaid Assets data on file, last reported at $76.3 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $76.3 million, up 70.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.3 million (up 70.21% YoY), and the FY2025 annual result was $66.4 million, up 62.84% from the prior year.
• Prepaid Assets improved to $76.3 million in Q1 2026 per PCVX's latest filing, from $66.4 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $76.3 million in Q1 2026 and troughed at $2.1 million in Q1 2024.
• A 5-year average of $28.3 million and a median of $18.6 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2025: Prepaid Assets slumped 88.77% in 2024, then soared 2043.02% in 2025.
• A 5-year view of Prepaid Assets shows it stood at $11.2 million in 2022, then jumped by 40.68% to $15.7 million in 2023, then surged by 159.28% to $40.8 million in 2024, then soared by 62.84% to $66.4 million in 2025, then rose by 14.92% to $76.3 million in 2026.
• Business Quant data shows PCVX's Prepaid Assets at $76.3 million in Q1 2026, $66.4 million in Q4 2025, and $55.8 million in Q3 2025.